par Agathe Masson | Mar 31, 2025 | Access to Care, NCD Policy, Actualités
Noncommunicable diseases (NCDs) are among the leading causes of death and disability worldwide, posing an immense burden on healthcare systems, economies, and individuals—especially in countries with a low Human Development Index (HDI). Recognising the urgency of...
par Agathe Masson | Déc 13, 2024 | Access to Care, NCD Solutions, Actualités
Every child deserves a fighting chance against cancer, regardless of where they are born. Yet, stark inequalities persist in access to pediatric oncology treatment, especially in low- and middle-income countries (LMICs). As purchasers responsible for securing...
par Agathe Masson | Déc 9, 2024 | Access to Care, NCD Solutions, Actualités
Sickle Cell Disease (SCD) is a genetic blood disorder that affects millions of people worldwide. Between 2010 and 2050, an estimated 14 million babies will be affected globally, with the vast majority born in low- and middle-income countries (LMICs). This staggering...
par Agathe Masson | Déc 9, 2024 | Access to Care, NCD Policy, Actualités
Access to essential treatments is a cornerstone of effective healthcare systems. Both brand-name medicines and generics play vital roles in ensuring that patients receive the care they need. While brand-name medicines are often associated with innovation and...
par Agathe Masson | Déc 9, 2024 | Access to Care, NCD Financing, Actualités
Success in improving access to cancer care is not about a one-size-fits-all approach; it involves addressing unmet needs with high-impact actions. In its comprehensive white paper, Improving Access to Affordable and Sustainable Oncological Care in Africa, IQVIA...
